−1.55 TWD
−91.01 M TWD
771.56 M TWD
35.94 M
About EXCELSIOR BIOPHARMA INC
Sector
CEO
Tse Min Chen
Headquarters
Taipei
Website
Founded
1988
ISIN
TW0006496003
FIGI
BBG007QK0PD1
Excelsior Biopharma Inc. engages in the research, development, manufacture, and distribution of pharmaceutical products. Its products include general medicines, rare disease drugs, antidotes, test reagents and oral care products. The company was founded on July 21, 1988 and is headquartered in Taipei, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6496 is 30.10 TWD — it has increased by 0.17% in the past 24 hours. Watch EXCELSIOR BIOPHARMA INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange EXCELSIOR BIOPHARMA INC stocks are traded under the ticker 6496.
6496 stock has risen by 0.33% compared to the previous week, the month change is a 1.35% rise, over the last year EXCELSIOR BIOPHARMA INC has showed a 3.26% increase.
6496 reached its all-time high on Dec 25, 2015 with the price of 151.45 TWD, and its all-time low was 22.25 TWD and was reached on Mar 23, 2020. View more price dynamics on 6496 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6496 stock is 2.68% volatile and has beta coefficient of 0.22. Track EXCELSIOR BIOPHARMA INC stock price on the chart and check out the list of the most volatile stocks — is EXCELSIOR BIOPHARMA INC there?
Today EXCELSIOR BIOPHARMA INC has the market capitalization of 1.38 B, it has decreased by −0.41% over the last week.
Yes, you can track EXCELSIOR BIOPHARMA INC financials in yearly and quarterly reports right on TradingView.
6496 net income for the last quarter is −22.30 M TWD, while the quarter before that showed −20.95 M TWD of net income which accounts for −6.46% change. Track more EXCELSIOR BIOPHARMA INC financial stats to get the full picture.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EXCELSIOR BIOPHARMA INC EBITDA is 9.99 M TWD, and current EBITDA margin is −4.52%. See more stats in EXCELSIOR BIOPHARMA INC financial statements.
Like other stocks, 6496 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EXCELSIOR BIOPHARMA INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EXCELSIOR BIOPHARMA INC technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EXCELSIOR BIOPHARMA INC stock shows the buy signal. See more of EXCELSIOR BIOPHARMA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.